The DOI matches its Crossref record; 270 of the 270 references it cites were found in a registry or an index.
Role of neuropeptides in anxiety, stress, and depression: From animals to humans
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Physiology and neurobiology of stress and adaptation: central role of the brain
McEwen, B. S. (2007) · Physiological Reviews · doi:10.1152/physrev.00041.2006 · Cited by 5,429 · cited 1×
“The equilibrium or homeostatic status of the body is continuously challenged by potentially noxious environmental factors (de Kloet et al., 2005; McEwen, 2007).”
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965 · cited 1×
“…corticotropin releasing factor (CRF) was identified and isolated by Wylie Wale and colleagues in 1981, it has been widely accepted that the CRF is the key regulator of the hypothalamus–pituitary–adrenal (HPA) axis and plays a crucial role in stress responses (Vale et al., 1981).”
VALE, W., SPIESS, J., RIVIER, C., & RIVIER, J. (1982) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198205000-00013 · Cited by 3,904
A Syndrome produced by Diverse Nocuous Agents
SELYE, H. (1936) · Nature · doi:10.1038/138032a0 · Cited by 3,903
The oxytocin receptor system: structure, function, and regulation
Gimpl, G., & Fahrenholz, F. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.629 · Cited by 3,089
Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress
Tsigos, C., & Chrousos, G. P. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(02)00429-4 · Cited by 2,822 · cited 1×
“Sensory systems perceive the stimuli called stressors and carry them into the limbic system, which controls the HPA axis (Tsigos and Chrousos, 2002).”
The Corticosteroid Receptor Hypothesis of Depression
Holsboer, F. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00159-7 · Cited by 2,181
Miyata, A., Arimura, A., Dahl, R. R., Minamino, N., Uehara, A., Jiang, L., Culler, M. D., & Coy, D. H. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)91757-9 · Cited by 1,830
Nemeroff, C. B., Widerlöv, E., Bissette, G., Walléus, H., Karlsson, I., Eklund, K., Kilts, C. D., Loosen, P. T., & Vale, W. (1984) · Science · doi:10.1126/science.6334362 · Cited by 1,485 · cited 5×
“, 2011), which is characteristic for a subset of depressed patients (Nemeroff et al., 1984).”
InfluentialVaughan, J., Donaldson, C., Bittencourt, J., Perrin, M. H., Lewis, K., Sutton, S., Chan, R., Turnbull, A. V., Lovejoy, D., Rivier, C., et al. (1995) · Nature · doi:10.1038/378287a0 · Cited by 1,479
Knobil and Neill's Physiology of Reproduction
(2015) · Elsevier eBooks · doi:10.1016/c2011-1-07288-0 · Cited by 1,272
CRF and CRF receptors: role in stress responsivity and other behaviors
Bale, T. L., & Vale, W. W. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121410 · Cited by 1,270
Disruption of two novel genes by a translocation co-segregating with schizophrenia
Millar, J. K. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.9.1415 · Cited by 1,254 · cited 2×
“Interestingly, disc1 gene mutation was linked not only to schizophrenia (Millar et al., 2000) but also to depression (Blackwood et al., 2001).”
Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery
Vaudry, D., Falluel-Morel, A., Bourgault, S., Basille, M., Burel, D., Wurtz, O., Fournier, A., Chow, B. K. C., Hashimoto, H., Galas, L., et al. (2009) · Pharmacological Reviews · doi:10.1124/pr.109.001370 · Cited by 1,058
Intra- and extrahypothalamic vasopressin and oxytocin pathways in the rat
Buijs, R. M., Swaab, D. F., Dogterom, J., & van Leeuwen, F. W. (1978) · Cell and Tissue Research · doi:10.1007/bf00224932 · Cited by 1,029 · cited 2×
“…suprachiasmatic nucleus, BNST, medial nucleus of the amygdala) exerting widespread central connections, suggesting a more complex role of AVP in daily rhythms, and limbic functions (Buijs, 1978), which is also supported by the broad distribution of central vasopressin receptors as described below.”
Lewis, K., Li, C., Perrin, M. H., Blount, A., Kunitake, K., Donaldson, C., Vaughan, J., Reyes, T. M., Gulyas, J., Fischer, W., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121165198 · Cited by 925
Chalmers, D., Lovenberg, T., & De Souza, E. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-10-06340.1995 · Cited by 919
Miyata, A., Jiang, L., Dahl, R. D., Kitada, C., Kubo, K., Fujino, M., Minamino, N., & Arimura, A. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)92140-u · Cited by 917
Neuroendocrine pharmacology of stress
Carrasco, G. A., & Van de Kar, L. D. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01285-8 · Cited by 914
Reyes, T. M., Lewis, K., Perrin, M. H., Kunitake, K. S., Vaughan, J., Arias, C. A., Hogenesch, J. B., Gulyas, J., Rivier, J., Vale, W. W., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051626398 · Cited by 887
Lovenberg, T. W., Liaw, C. W., Grigoriadis, D. E., Clevenger, W., Chalmers, D. T., De Souza, E. B., & Oltersdorf, T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.836 · Cited by 846
Buijs, R. M. (1978) · Cell and Tissue Research · doi:10.1007/bf00212323 · Cited by 830
Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor
Ressler, K. J., Mercer, K. B., Bradley, B., Jovanovic, T., Mahan, A., Kerley, K., Norrholm, S. D., Kilaru, V., Smith, A. K., Myers, A. J., et al. (2011) · Nature · doi:10.1038/nature09856 · Cited by 800
Blackwood, D. H. R., Fordyce, A., Walker, M. T., St. Clair, D. M., Porteous, D. J., & Muir, W. J. (2001) · The American Journal of Human Genetics · doi:10.1086/321969 · Cited by 733
Silverman, M. N., & Sternberg, E. M. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06633.x · Cited by 731
Sawchenko, P. E., Swanson, L. W., Grzanna, R., Howe, P. R. C., Bloom, S. R., & Polak, J. M. (1985) · Journal of Comparative Neurology · doi:10.1002/cne.902410203 · Cited by 663
Hsu, S. Y., & Hsueh, A. J. W. (2001) · Nature Medicine · doi:10.1038/87936 · Cited by 650
Bielsky, I. F., Hu, S.-B., Szegda, K. L., Westphal, H., & Young, L. J. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300360 · Cited by 531
Modulation of Anxiety and Neuropeptide Y-Y1 Receptors by Antisense Oligodeoxynucleotides
Wahlestedt, C., Pich, E. M., Koob, G. F., Yee, F., & Heilig, M. (1993) · Science · doi:10.1126/science.8380941 · Cited by 527
Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need
Muglia, L., Jacobson, L., Dikkes, P., & Majzoub, J. A. (1995) · Nature · doi:10.1038/373427a0 · Cited by 524 · cited 1×
“As expected, CRF deficient mice exert reduced glucocorticoid production suggesting the insufficiency of the HPA axis, but no behavioral alterations were demonstrated (Muglia et al., 1995).”
Potter, E., Sutton, S., Donaldson, C., Chen, R., Perrin, M., Lewis, K., Sawchenko, P. E., & Vale, W. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8777 · Cited by 514
REM sleep dysregulation in depression: state of the art
Palagini, L., Baglioni, C., Ciapparelli, A., Gemignani, A., & Riemann, D. (2013) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2012.11.001 · Cited by 513 · cited 1×
“…REM phases similarly to all classic antidepressant medications (i.e., tricyclic antidepressants, monoamine-oxidase inhibitors, selective serotonin re-uptake inhibitors, serotonine norepinephrine re-uptake inhibitors; noradrenaline re-uptake inhibitors) (for review see: Palagini et al., 2013). dels.”
Neuromodulation by Oxytocin and Vasopressin
Stoop, R. (2012) · Neuron · doi:10.1016/j.neuron.2012.09.025 · Cited by 506
Stress Hormone Regulation: Biological Role and Translation into Therapy
Holsboer, F., & Ising, M. (2010) · Annual Review of Psychology · doi:10.1146/annurev.psych.093008.100321 · Cited by 473 · cited 3×
“…by the determination of the affected neuropeptide(s) and other elements of the stress systems, leading to personalized ‘‘subtype’’ specific therapy (Holsboer and Ising, 2010), opening new avenues in the management of mood disorders with higher therapeutic efficacy than that of the…”
InfluentialStenzel-Poore, M., Heinrichs, S., Rivest, S., Koob, G., & Vale, W. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-05-02579.1994 · Cited by 468
Engelmann, M., Landgraf, R., & Wotjak, C. T. (2004) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2004.09.001 · Cited by 450
Wray, N. R., Pergadia, M. L., Blackwood, D. H. R., Penninx, B. W. J. H., Gordon, S. D., Nyholt, D. R., Ripke, S., MacIntyre, D. J., McGhee, K. A., Maclean, A. W., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2010.109 · Cited by 444
Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor
Perrin, M. H., Donaldson, C. J., Chen, R., Lewis, K. A., & Vale, W. (1993) · Endocrinology · doi:10.1210/en.133.6.3058 · Cited by 437
Joëls, M., Sarabdjitsingh, R. A., & Karst, H. (2012) · Pharmacological Reviews · doi:10.1124/pr.112.005892 · Cited by 425
Role of the Y5 neuropeptide Y receptor in feeding and obesity
Marsh, D. J., Hollopeter, G., Kafer, K. E., & Palmiter, R. D. (1998) · Nature Medicine · doi:10.1038/nm0698-718 · Cited by 416
Vasopressin V1a and V1b Receptors: From Molecules to Physiological Systems
Koshimizu, T.-A., Nakamura, K., Egashira, N., Hiroyama, M., Nonoguchi, H., & Tanoue, A. (2012) · Physiological Reviews · doi:10.1152/physrev.00035.2011 · Cited by 407
Merali, Z., Du, L., Hrdina, P., Palkovits, M., Faludi, G., Poulter, M. O., & Anisman, H. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4734-03.2004 · Cited by 400
Bakermans-Kranenburg, M. J., & van IJzendoorn, M. H. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.34 · Cited by 383
The CRF system, stress, depression and anxiety—insights from human genetic studies
Binder, E. B., & Nemeroff, C. B. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.141 · Cited by 379
Aguilera, G., & Rabadan-Diehl, C. (2000) · Regulatory Peptides · doi:10.1016/s0167-0115(00)00196-8 · Cited by 375 · cited 2×
“…on CRF1 receptor; interestingly, glucocorticoids cause an up-regulation of V1b receptor mRNA expression, therefore, it was suggested that the role of AVP/V1b in the pituitary is to maintain the high HPA axis activity in chronic stress (Aguilera and Rabadan-Diehl, 2000; Lightman et al., 2002).”
Stress, genes and the mechanism of programming the brain for later life
de Kloet, E. R., Sibug, R. M., Helmerhorst, F. M., & Schmidt, M. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2004.10.008 · Cited by 375
Hashimoto, H., Shintani, N., Tanaka, K., Mori, W., Hirose, M., Matsuda, T., Sakaue, M., Miyazaki, J.-I., Niwa, H., Tashiro, F., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231094498 · Cited by 373
Bielsky, I. F., Hu, S.-B., Ren, X., Terwilliger, E. F., & Young, L. J. (2005) · Neuron · doi:10.1016/j.neuron.2005.06.031 · Cited by 367
Hillhouse, E. W., & Grammatopoulos, D. K. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0034 · Cited by 353
Walker, D. L., Miles, L. A., & Davis, M. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.06.022 · Cited by 331
Anxiety and stress responses in female oxytocin deficient mice
Amico, J. A., Mantella, R. C., Vollmer, R. R., & Li, X. (2004) · Journal of Neuroendocrinology · doi:10.1111/j.0953-8194.2004.01161.x · Cited by 327
Thorsell, A., Michalkiewicz, M., Dumont, Y., Quirion, R., Caberlotto, L., Rimondini, R., Mathé, A. A., & Heilig, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220232997 · Cited by 315
The role of substance P in stress and anxiety responses
Ebner, K., & Singewald, N. (2006) · Amino Acids · doi:10.1007/s00726-006-0335-9 · Cited by 306
Cohen, H., Liu, T., Kozlovsky, N., Kaplan, Z., Zohar, J., & Mathé, A. A. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.230 · Cited by 299
Ostrowski, N. L. (1994) · Endocrinology · doi:10.1210/en.135.4.1511 · Cited by 290
Behavioral characterization of neuropeptide Y knockout mice
Bannon, A. W., Seda, J., Carmouche, M., Francis, J. M., Norman, M. H., Karbon, B., & McCaleb, M. L. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02285-x · Cited by 290
Lederis, K., Letter, A., McMaster, D., Moore, G., & Schlesinger, D. (1982) · Science · doi:10.1126/science.6981844 · Cited by 286
Distribution of galanin-1, -2 and -3 receptor messenger RNAs in central and peripheral rat tissues
Waters, S. M., & Krause, J. E. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00407-8 · Cited by 278
Immunohistochemical localization of oxytocin receptors in human brain
Boccia, M. L., Petrusz, P., Suzuki, K., Marson, L., & Pedersen, C. A. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.08.048 · Cited by 276
Hernando, F. (2001) · Endocrinology · doi:10.1210/en.142.4.1659 · Cited by 275
Xu, Y., Gall, C. M., Jackson, V. R., Civelli, O., & Reinscheid, R. K. (2007) · Journal of Comparative Neurology · doi:10.1002/cne.21159 · Cited by 272
A conditional knockout mouse line of the oxytocin receptor
Lee, H.-J., Caldwell, H. K., Macbeth, A. H., Tolu, S. G., & Young, W. S. (2008) · Endocrinology · doi:10.1210/en.2007-1710 · Cited by 269
Binneman, B., Feltner, D., Kolluri, S., Shi, Y., Qiu, R., & Stiger, T. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07071199 · Cited by 254 · cited 2×
“However, Binneman et al. (2008) in their clinical study failed to show the significant beneficial effects of the CRF1 receptor antagonist CP-316,311 (Binneman et al., 2008).”
Hannibal, J. (2002) · Journal of Comparative Neurology · doi:10.1002/cne.10418 · Cited by 247
Sajdyk, T. J., Vandergriff, M. G., & Gehlert, D. R. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00018-7 · Cited by 241
Stress-induced behaviors require the corticotropin-releasing hormone (CRH) receptor, but not CRH
Weninger, S. C., Dunn, A. J., Muglia, L. J., Dikkes, P., Miczek, K. A., Swiergiel, A. H., Berridge, C. W., & Majzoub, J. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.8283 · Cited by 241
Li, C., Vaughan, J., Sawchenko, P. E., & Vale, W. W. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-03-00991.2002 · Cited by 239
Hammack, S. E., Cheung, J., Rhodes, K. M., Schutz, K. C., Falls, W. A., Braas, K. M., & May, V. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.12.013 · Cited by 231
Ebner, K., Rupniak, N. M., Saria, A., & Singewald, N. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400794101 · Cited by 225
Irwin, M., Brown, M., Patterson, T., Hauger, R., Mascovich, A., & Grant, I. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.15.1743441 · Cited by 219
A possible role of neuropeptide Y in depression and stress
Morales-Medina, J. C., Dumont, Y., & Quirion, R. (2010) · Brain Research · doi:10.1016/j.brainres.2009.09.077 · Cited by 218
Lightman, S. L., & Young, W. S. (1988) · The Journal of Physiology · doi:10.1113/jphysiol.1988.sp017261 · Cited by 215
Kalin, N. H., Takahashi, L. K., & Chen, F.-L. (1994) · Brain Research · doi:10.1016/0006-8993(94)91382-x · Cited by 211
Gal, C. S.-L., Wagnon, J., Simiand, J., Griebel, G., Lacour, C., Guillon, G., Barberis, C., Brossard, G., Soubrié, P., Nisato, D., et al. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.3.1122 · Cited by 211
Epigenetic regulation of the oxytocin receptor gene: implications for behavioral neuroscience
Kumsta, R., Hummel, E., Chen, F. S., & Heinrichs, M. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00083 · Cited by 207 · cited 3×
“…stress vulnerability McQuaid et al. (2013) Reversal of depression like phenotype of HAB rats Slattery and Neumann (2010) Epigenetic changes in the OXTR gene Kumsta et al. (2013b) Clinical trials on OXTR antagonists with promising results Catena-Dell’Osso et al. (2013) KO: knockout animals; OXT:…”
Oxytocin acts as an antidepressant in two animal models of depression
Arletti, R., & Bertolini, A. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90600-x · Cited by 203
Kozicz, T., Bittencourt, J. C., May, P. J., Reiner, A., Gamlin, P. D. R., Palkovits, M., Horn, A. K. E., Toledo, C. A. B., & Ryabinin, A. E. (2011) · Journal of Comparative Neurology · doi:10.1002/cne.22580 · Cited by 203
Female oxytocin-deficient mice display enhanced anxiety-related behavior
Mantella, R. C., Vollmer, R. R., Li, X., & Amico, J. A. (2003) · Endocrinology · doi:10.1210/en.2002-0197 · Cited by 200
Chronic icv oxytocin attenuates the pathological high anxiety state of selectively bred Wistar rats
Slattery, D. A., & Neumann, I. D. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.06.038 · Cited by 195
Egashira, N., Tanoue, A., Matsuda, T., Koushi, E., Harada, S., Takano, Y., Tsujimoto, G., Mishima, K., Iwasaki, K., & Fujiwara, M. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.12.009 · Cited by 193
Neuropeptide S Stimulates the Hypothalamo-Pituitary-Adrenal Axis and Inhibits Food Intake
Smith, K. L., Patterson, M., Dhillo, W. S., Patel, S. R., Semjonous, N. M., Gardiner, J. V., Ghatei, M. A., & Bloom, S. R. (2006) · Endocrinology · doi:10.1210/en.2005-1280 · Cited by 186
Neuroanatomical localisation of Substance P in the CNS and sensory neurons
Ribeiro-da-Silva, A., & Hökfelt, T. (2000) · Neuropeptides · doi:10.1054/npep.2000.0834 · Cited by 185
American Psychiatric Association
(2014) · Cultural Sociology of Mental Illness: An A-to-Z Guide · doi:10.4135/9781483346342.n10 · Cited by 185
Liposits, Z., Sievers, L., & Paull, W. K. (1988) · Histochemistry · doi:10.1007/bf00570278 · Cited by 182
Reduced anxiety and improved stress coping ability in mice lacking NPY‐Y2 receptors
Tschenett, A., Singewald, N., Carli, M., Balducci, C., Salchner, P., Vezzani, A., Herzog, H., & Sperk, G. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02725.x · Cited by 180
The vasopressin system — From antidiuresis to psychopathology
Frank, E., & Landgraf, R. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.063 · Cited by 179
Merali, Z., Kent, P., Du, L., Hrdina, P. D., Palkovits, M., Faludi, G., Poulter, M. O., Bédard, T., & Anisman, H. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.08.008 · Cited by 174
Urocortin-deficient mice show hearing impairment and increased anxiety-like behavior
Vetter, D. E., Li, C., Zhao, L., Contarino, A., Liberman, M. C., Smith, G. W., Marchuk, Y., Koob, G. F., Heinemann, S. F., Vale, W., et al. (2002) · Nature Genetics · doi:10.1038/ng914 · Cited by 173
Ma, X.-M., Levy, A., & Lightman, S. L. (1997) · Endocrinology · doi:10.1210/endo.138.10.5446 · Cited by 171
Neuropeptide Y (NPY) and depression: From animal studies to the human condition
Redrobe, J. P., Dumont, Y., & Quirion, R. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)02159-8 · Cited by 168
Makino, S., Shibasaki, T., Yamauchi, N., Nishioka, T., Mimoto, T., Wakabayashi, I., Gold, P. W., & Hashimoto, K. (1999) · Brain Research · doi:10.1016/s0006-8993(99)02114-9 · Cited by 167
Neuropeptides in learning and memory
Borbély, É., Scheich, B., & Helyes, Z. (2013) · Neuropeptides · doi:10.1016/j.npep.2013.10.012 · Cited by 166
Diverse functions of neuropeptide Y revealed using genetically modified animals
Thorsell, A., & Heilig, M. A. (2002) · Neuropeptides · doi:10.1054/npep.2002.0897 · Cited by 166
Weninger, S. C., Peters, L. L., & Majzoub, J. A. (2000) · Endocrinology · doi:10.1210/endo.141.1.7277 · Cited by 161
Diminished Anxiety- and Depression-Related Behaviors in Mice with Selective Deletion of theTac1Gene
Bilkei‐Gorzó, A., Rácz, I., Michel, K., & Zimmer, A. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-22-10046.2002 · Cited by 161
McQuaid, R. J., McInnis, O. A., Stead, J. D., Matheson, K., & Anisman, H. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00128 · Cited by 158
Thorsell, A., Carlsson, K., Ekman, R., & Heilig, M. A. (1999) · Neuroreport · doi:10.1097/00001756-199909290-00024 · Cited by 158
Lolait, S. J., Stewart, L. Q., Jessop, D. S., Young, W. S., & O’Carroll, A. (2006) · Endocrinology · doi:10.1210/en.2006-1309 · Cited by 157
Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist
Ring, R. H., Schechter, L. E., Leonard, S. K., Dwyer, J. M., Platt, B. J., Graf, R., Grauer, S. M., Pulicicchio, C. M., Resnick, L., Rahman, Z. U., et al. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.07.016 · Cited by 156
Hsu, D. T., Chen, F.-L., Takahashi, L. K., & Kalin, N. H. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00032-8 · Cited by 154
Webling, K., Runesson, J., Bartfai, T., & Langel, Ü. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00146 · Cited by 154
Valdez, G. R., Zorrilla, E. P., Rivier, J., Vale, W., & Koob, G. F. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02971-8 · Cited by 153
Rupniak, N. M. J., Carlson, E. J., Webb, J. K., Harrison, T., Porsolt, R. D., Roux, S., Felipe, C. D., Hunt, S. P., Oates, B. D., & Wheeldon, A. (2001) · Behavioural Pharmacology · doi:10.1097/00008877-200111000-00011 · Cited by 151
Low Cerebrospinal Fluid Neuropeptide Y Concentrations in Posttraumatic Stress Disorder
Sah, R., Ekhator, N. N., Strawn, J. R., Sallee, F. R., Baker, D. G., Horn, P. S., & Geracioti, T. D. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.04.037 · Cited by 151
Galanin – 25 years with a multitalented neuropeptide
Mitsukawa, K., Lü, X., & Bartfai, T. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8153-8 · Cited by 151
Altered emotional behavior in PACAP-type-I-receptor-deficient mice
Otto, C., Martin, M., Wolfer, D. P., Lipp, H.-P., Maldonado, R. J., & Schütz, G. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00153-x · Cited by 150
Skelton, K. H., Owens, M. J., & Nemeroff, C. B. (2000) · Regulatory Peptides · doi:10.1016/s0167-0115(00)00180-4 · Cited by 148
Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders
Leonard, S. K., Dwyer, J. M., Rizzo, S. J. S., Platt, B. J., Logue, S. F., Webb, S. J. N., Malberg, J. E., Beyer, C. E., Schechter, L. E., Rosenzweig-Lipson, S. J., et al. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1080-4 · Cited by 148
Henry, B., Vale, W., & Markou, A. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1494-06.2006 · Cited by 147
Inactivation of a Novel Neuropeptide Y/Peptide YY Receptor Gene in Primate Species
Matsumoto, M., Nomura, T., Momose, K., Ikeda, Y., Kondou, Y., Akiho, H., Togami, J., Kimura, Y., Okada, M., & Yamaguchi, T. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27217 · Cited by 146
The Central Vasopressinergic System: Examining the Opportunities for Psychiatric Drug Development
Ring, R. H. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053382241 · Cited by 145
Flandreau, E. I., Ressler, K. J., Owens, M. J., & Nemeroff, C. B. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.04.014 · Cited by 143
Lehmann, M. L., Mustafa, T., Eiden, A. M., Herkenham, M. A., & Eiden, L. E. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.09.006 · Cited by 142
Neuropeptide-Y exerts antidepressant-like effects in the forced swim test in rats
Stogner, K. A., & Holmes, P. V. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00800-6 · Cited by 142
Hammack, S. E., Roman, C. W., Lezak, K. R., Kocho-Schellenberg, M., Grimmig, B. A., Falls, W. A., Braas, K. M., & May, V. (2010) · Journal of Molecular Neuroscience · doi:10.1007/s12031-010-9364-7 · Cited by 142
Hammack, S. E., Cooper, M. A., & Lezak, K. R. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.02.024 · Cited by 142 · cited 2×
“…been previously studied in animal models (Kalin et al., 1994; Hsu et al., 1998; Makino et al., 1999; for reviews see: Carrasco and Van de Kar, 2003; Hammack et al., 2012; Kehne and Cain, 2010; Kovács, 2013) and post mortem samples of suicide victims (Nemeroff et al., 1984; Bissette et al., 2003;…”
Galanin: A Significant Role in Depression?
Weiss, J. M., Bonsall, R. W., Demetrikopoulos, M. K., Emery, M., & West, C. H. K. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb10707.x · Cited by 141
Urocortin 3 regulates glucose-stimulated insulin secretion and energy homeostasis
Li, C., Chen, P., Vaughan, J. M., Lee, K., & Vale, W. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611641104 · Cited by 140
HPA axis dysregulation in mice overexpressing corticotropin releasing hormone
Groenink, L., Dirks, A., Verdouw, P. M., Schipholt, M. L., Veening, J. G., van der Gugten, J., & Olivier, B. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01334-3 · Cited by 140
Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation
Sørensen, G., Lindberg, C., Wörtwein, G., Bolwig, T. G., & Woldbye, D. P. D. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20200 · Cited by 137
Role of the Y5 neuropeptide Y receptor in limbic seizures
Marsh, D. J., Baraban, S. C., Hollopeter, G., & Palmiter, R. D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13518 · Cited by 137
Suda, T., TOZAWA, F., Iwai, I., Sato, Y., Sumitomo, T., Nakano, Y., Yamada, M., & Demura, H. (1993) · Molecular Brain Research · doi:10.1016/0169-328x(93)90094-6 · Cited by 136
A role for galanin in antidepressant actions with a focus on the dorsal raphe nucleus
Lü, X., Barr, A. M., Kinney, J. W., Sanna, P. P., Conti, B., Behrens, M. M., & Bartfai, T. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408891102 · Cited by 136
Elevated Concentrations of CRF in the Locus Coeruleus of Depressed Subjects
Bissette, G., Klimek, V., Pan, J., Stockmeier, C., & Ordway, G. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300191 · Cited by 136
Reduced aggressive behaviour in mice with targeted disruption of the oxytocin gene
DeVries, A. C., Young III, W. S., & Nelson, R. J. (1997) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.1997.t01-1-00589.x · Cited by 134 · cited 3×
“OXT injection, HAB rats: depression ; Arletti and Bertolini (1987), Ring et al. (2010) Anxiety: – DeVries et al. (1997) anxiety " in $ Mantella et al. (2003) Anxiety " Amico et al. (2004) OXT " in abused girls Seltzer et al. (2013) OXTR Antagonist: Depression: – Anxiety – Depression – Lee et al.…”
Treatment with the CRH1-receptor-antagonist R121919 improves sleep-EEG in patients with depression
Held, K., Kunzel, H. E., Ising, M., Schmid, D. A., Zobel, A. W., Murck, H., Holsboer, F., & Steiger, A. (2003) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(03)00076-1 · Cited by 134
Okamura, N., Hashimoto, K., Iyo, M., Shimizu, E., Dempfle, A., Friedel, S., & Reinscheid, R. K. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.06.026 · Cited by 133
Elevation of substance P-like peptides in the CSF of psychiatric patients.
Rimón, R., Le Grevés, P., Nyberg, F., et al. (1984) · PubMed · Cited by 132
Agarwal, A., Halvorson, L. M., & Légrádi, G. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2005.03.016 · Cited by 131
Herman, J. P. (1995) · Journal of Comparative Neurology · doi:10.1002/cne.903630103 · Cited by 129
Substance P serum levels are increased in major depression: preliminary results
Bondy, B., Baghai, T. C., Minov, C., Schüle, C., Schwarz, M., Zwanzger, P., Rupprecht, R., & Möller, H. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01544-5 · Cited by 129
Seltzer, L. J., Ziegler, T. E., Connolly, M. J., Prososki, A. R., & Pollak, S. D. (2013) · Child Development · doi:10.1111/cdev.12136 · Cited by 128
PACAP: a master regulator of neuroendocrine stress circuits and the cellular stress response
Stroth, N., Holighaus, Y., Aït‐Ali, D., & Eiden, L. E. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.05904.x · Cited by 127
CRH: the link between hormonal-, metabolic- and behavioral responses to stress
Kovács, K. J. (2013) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2013.05.003 · Cited by 126 · cited 2×
“…animal models (Kalin et al., 1994; Hsu et al., 1998; Makino et al., 1999; for reviews see: Carrasco and Van de Kar, 2003; Hammack et al., 2012; Kehne and Cain, 2010; Kovács, 2013) and post mortem samples of suicide victims (Nemeroff et al., 1984; Bissette et al., 2003; Merali et al., 2004, 2006).”
Venihaki, M., Sakihara, S., Subramanian, S. B., Dikkes, P., Weninger, S. C., Liapakis, G., Graf, T., & Majzoub, J. A. (2004) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2004.01170.x · Cited by 126
Stroth, N., & Eiden, L. E. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.11.023 · Cited by 124
Gaszner, B., CSERNUS, V. J., & Kozicz, T. (2004) · The Journal of Comparative Neurology · doi:10.1002/cne.20343 · Cited by 121
Self-citationPACAP is an Endogenous Protective Factor—Insights from PACAP-Deficient Mice
Reglődi, D., Kiss, P., Szabadfi, K., Atlasz, T., Gabriel, R., Horváth, G., Szakály, P., Sandor, B., Lubics, A., László, E., et al. (2012) · Journal of Molecular Neuroscience · doi:10.1007/s12031-012-9762-0 · Cited by 120
Sink, K. S., Walker, D. L., Freeman, S. M., Flandreau, E. I., Ressler, K. J., & Davis, M. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.188 · Cited by 120
Kehne, J. H., & Cain, C. K. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.08.011 · Cited by 117
Ebner, K., Muigg, P., Singewald, G. M., & Singewald, N. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1418.018 · Cited by 116
Karlsson, R., Choe, J. S., Cameron, H. A., Thorsell, A., Crawley, J. N., Holmes, A., & Heilig, M. A. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0945-2 · Cited by 115
Gaszner, B., Kormos, V., Kozicz, T., Hashimoto, H., Reglődi, D., & Helyes, Z. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.11.046 · Cited by 115
Self-citationStress-Related Neuropeptides and Addictive Behaviors: Beyond the Usual Suspects
Schank, J. R., Ryabinin, A. E., Giardino, W. J., Ciccocioppo, R., & Heilig, M. A. (2012) · Neuron · doi:10.1016/j.neuron.2012.09.026 · Cited by 114
OxytocinSynthesis, Secretion, and Reproductive Functions
BURBACH, J., YOUNG, L., & RUSSELL, J. (2006) · Knobil and Neill's Physiology of Reproduction · doi:10.1016/b978-012515400-0/50063-4 · Cited by 113
Pelleymounter, M. A., Joppa, M. A., Ling, N., & Foster, A. C. (2004) · Peptides · doi:10.1016/j.peptides.2004.01.008 · Cited by 113
Regev, L., Neufeld-Cohen, A., Tsoory, M., Kuperman, Y., Getselter, D., Gil, S., & Chen, A. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.64 · Cited by 110
Suppressed neuropeptide Y (NPY) mRNA in rat amygdala following restraint stress
Thorsell, A., Svensson, P., Wiklund, L., Sommer, W. H., Ekman, R., & Heilig, M. A. (1998) · Regulatory Peptides · doi:10.1016/s0167-0115(98)00075-5 · Cited by 109
A triple urocortin knockout mouse model reveals an essential role for urocortins in stress recovery
Neufeld-Cohen, A., Tsoory, M., Evans, A. K., Getselter, D., Gil, S., Lowry, C. A., Vale, W., & Chen, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013761107 · Cited by 109
ISOLATION AND AMINO ACID COMPOSITION OF SAUVAGINE
Montecucchi, P. C., Anastasi, A., Castiglione, R., & Erspamer, V. (1980) · International journal of peptide & protein research · doi:10.1111/j.1399-3011.1980.tb02952.x · Cited by 109
Hashimoto, H., Hashimoto, R., Shintani, N., Tanaka, K., Yamamoto, A., Hatanaka, M., Guo, X., Morita, Y., Tanida, M., Nagai, K., et al. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06168.x · Cited by 108
Galanin, Galanin Receptor Subtypes and Depression-Like Behaviour
Kuteeva, E., Hökfelt, T. G. M., Wardi, T., & Ögren, S. O. (2010) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-0346-0228-0_12 · Cited by 106
Behavioral phenotyping of Neuropeptide S receptor knockout mice
Duangdao, D. M., Clark, S. D., Okamura, N., & Reinscheid, R. K. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.07.024 · Cited by 106
Hattori, T., Baba, K., Matsuzaki, S., Honda, A., Miyoshi, K., Inoue, K., Taniguchi, M., Hashimoto, H., Shintani, N., Baba, A., et al. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001945 · Cited by 106
Bailey, K. R., Pavlova, M. N., Rohde, A. D., Hohmann, J. G., & Crawley, J. N. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.11.024 · Cited by 106
Almli, L. M., Mercer, K. B., Kerley, K. A., Feng, H., Bradley, B., Conneely, K. N., & Ressler, K. J. (2013) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32145 · Cited by 104
Mak, P., Broussard, C., Vacy, K., & Broadbear, J. H. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111416687 · Cited by 103
Dannlowski, U., Kugel, H., Franke, F., Stuhrmann, A., Hohoff, C., Zwanzger, P., Lenzen, T., Grotegerd, D., Suslow, T., Arolt, V., et al. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.73 · Cited by 102
Kask, A., Rägo, L., & Harro, J. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00838-2 · Cited by 97
Endocrine function of neuropeptide Y knockout mice
Erickson, J. C., Ahima, R. S., Hollopeter, G., Flier, J. S., & Palmiter, R. D. (1997) · Regulatory Peptides · doi:10.1016/s0167-0115(97)01007-0 · Cited by 96
Husum, H., van Kammen, D., Termeer, E. H., Bolwig, T. G., & Mathé, A. A. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300178 · Cited by 96
Montecucchi, P. C., Anastasi, A., Castiglione, R., & Erspamer, V. (1980) · PubMed · Cited by 95
Woldbye, D. P. D., Ängehagen, M., Gøtzsche, C. R., Elbrønd-Bek, H., Sørensen, A. T., Christiansen, S. H., Olesen, M. V., Nikitidou, L., Hansen, T. V. O., Kanter‐Schlifke, I., et al. (2010) · Brain · doi:10.1093/brain/awq219 · Cited by 95
de Souza, M. A., Centenaro, L. A., Menegotto, P. R., Henriques, T. P., Bonini, J. S., Achaval, M., & Lucion, A. B. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1049-5 · Cited by 95
Cohen, H., Kaplan, Z., Kozlovsky, N., Gidron, Y., Matar, M. A., & Zohar, J. (2010) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2010.02003.x · Cited by 94
Kozicz, T., Ouwens, D. T. W. M., Faludi, G., Palkovits, M., & Roubos, E. W. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2007.12.050 · Cited by 93
Chen, A., Zorrilla, E. P., Smith, S., Rousso, D. L., Levy, C. L., Vaughan, J. M., Donaldson, C., Roberts, A. L., Lee, K., & Vale, W. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3955-05.2006 · Cited by 93
Galanin – 25 years with a multitalented neuropeptide
Kuteeva, E., Hökfelt, T. G. M., Wardi, T., & Ögren, S. O. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8160-9 · Cited by 92
Dirks, A., Groenink, L., Bouwknecht, J. A., Hijzen, T. H., van der Gugten, J., Ronken, E., Verbeek, J. S., Veening, J. G., Dederen, P. J. W. C., Kőrösi, A., et al. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02245.x · Cited by 91
Wahlestedt, C., Ekman, R., & Widerlöv, E. (1989) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(89)90003-1 · Cited by 90
Johnson, A. E., Audigier, S., Rossi, F., Jard, S., Tribollet, E., & Barberis, C. (1993) · Brain Research · doi:10.1016/0006-8993(93)90795-o · Cited by 89
Greenman, Y., Kuperman, Y., Drori, Y., Asa, S. L., Navon, I., Forkosh, O., Gil, S., Stern, N., & Chen, A. (2013) · Molecular Endocrinology · doi:10.1210/me.2012-1344 · Cited by 89
Hannibal, J., Mikkelsen, J. D., Fahrenkrug, J., & Larsen, P. J. (1995) · Endocrinology · doi:10.1210/endo.136.9.7649120 · Cited by 89
Hypothalamic–pituitary–adrenal function
Lightman, S. L., Windle, R. J., Ma, X.-M., Harbuz, M. S., Shanks, N. M., Julian, M. D., Wood, S. A., Kershaw, Y. M., & Ingram, C. D. (2002) · Archives of Physiology and Biochemistry · doi:10.1076/apab.110.1.90.899 · Cited by 88
Deussing, J. M., Breu, J., Kuhne, C., Kallnik, M., Bunck, M., Glasl, L., Yen, Y.-C., Schmidt, M. V., Zurmuhlen, R., Vogl, A. M., et al. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1049-10.2010 · Cited by 86 · cited 1×
“Deussing et al. (2010) generated another knockout line and found that the lack of UCN3 does not cause any alterations in anxiety and depression measures, but processing of social cues and memories are changed.”
Das, M., Vihlen, C. S., & Légrádi, G. (2006) · The Journal of Comparative Neurology · doi:10.1002/cne.21212 · Cited by 85
Phenotypic Analysis of Mice Deficient in the Type 2 Galanin Receptor (GALR2)
Gottsch, M. L., Zeng, H., Hohmann, J. G., Weinshenker, D., Clifton, D. K., & Steiner, R. A. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.11.4804-4811.2005 · Cited by 85
PACAP is Implicated in the Stress Axes
Hashimoto, H., Shintani, N., Tanida, M., Hayata, A., Hashimoto, R., & Baba, A. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211795589382 · Cited by 85
Girard, B. A., Lelièvre, V., Braas, K. M., Razinia, T., Vizzard, M. A., Ioffe, Y., Meskini, R. E., Ronnett, G. V., Waschek, J. A., & May, V. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04112.x · Cited by 84
Wang, X., Su, H., Copenhagen, L. D., Vaishnav, S., Pieri, F., Shope, C. D., Brownell, W. E., Biasi, M. D., Paylor, R. E., & Bradley, A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.18.6605-6610.2002 · Cited by 83
Distribution and developmental changes in vasopressin V2 receptor mRNA in rat brain
Kato, Y., Igarashi, N., Hirasawa, A., Tsujimoto, G., & Kobayashi, M. (1995) · Differentiation · doi:10.1046/j.1432-0436.1995.5930163.x · Cited by 82
Galanin, Galanin Receptors, and Drug Targets
Mitsukawa, K., Lu, X., & Bartfai, T. (2010) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-0346-0228-0_2 · Cited by 82
Griebel, G., Beeské, S., & Stahl, S. M. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12m07804 · Cited by 81
Editorial comment: Oxytocin, vasopressin and social behavior
Young, L. J., & Flanagan-Cato, L. M. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2012.02.019 · Cited by 81
Perifornical Urocortin-3 mediates the link between stress-induced anxiety and energy homeostasis
Kuperman, Y., Issler, O., Regev, L., Musseri, I., Navon, I., Neufeld-Cohen, A., Gil, S., & Chen, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003969107 · Cited by 81
Staub, D. R., Spiga, F., & Lowry, C. A. (2005) · Brain Research · doi:10.1016/j.brainres.2005.02.080 · Cited by 80
Morales‐Medina, J. C., Dumont, Y., Benoit, C.-É., Bastianetto, S., Flores, G., Fournier, A., & Quirion, R. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.06.030 · Cited by 80
CRF Mediates the Anxiogenic and Anti-Rewarding, But Not the Anorectic Effects of PACAP
Dore, R., Iemolo, A., Smith, K. L., Wang, X., Cottone, P., & Sabino, V. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.113 · Cited by 80
Reduced anxiety-like and depression-related behavior in neuropeptide Y Y4 receptor knockout mice
Painsipp, E., Wultsch, T., Edelsbrunner, M. E., Tasan, R. O., Singewald, N., Herzog, H., & Holzer, P. (2008) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2008.00389.x · Cited by 79 · cited 3×
“Y4 receptor deficient mice were shown to have reduced anxiety and depression like behavior (Painsipp et al., 2008), and Y2/Y4 double knockout mice showed further decreased depression levels (Tasan et al., 2009).”
Phenotypic analysis of GalR2 knockout mice in anxiety- and depression-related behavioral tests
Lü, X., Ross, B. S., Sánchez-Alavez, M., Zorrilla, E. P., & Bartfai, T. (2008) · Neuropeptides · doi:10.1016/j.npep.2008.04.009 · Cited by 79
Modulation of neuropeptide Y expression in adult mice does not affect feeding
Marie, L. S., Luquet, S. H., Cole, T. B., & Palmiter, R. D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509240102 · Cited by 75
Janssen, D., & Kozicz, T. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00028 · Cited by 74
Molecular fingerprint of neuropeptide s‐producing neurons in the mouse brain
Liu, X., Zeng, J., Zhou, A., Theodorsson, E., Fahrenkrug, J., & Reinscheid, R. K. (2011) · The Journal of Comparative Neurology · doi:10.1002/cne.22603 · Cited by 74
Zhu, H., Mingler, M. K., McBride, M. L., Murphy, A. J., Valenzuela, D. M., Yancopoulos, G. D., Williams, M. T., Vorhees, C. V., & Rothenberg, M. E. (2010) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.01.012 · Cited by 73
Hashimoto, R., Hashimoto, H., Shintani, N., Ohi, K., Hori, H., Saitoh, O., Kosuga, A., Tatsumi, M., Iwata, N., Ozaki, N., et al. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.11.019 · Cited by 72
Tasan, R. O., Lin, S., Hetzenauer, A., Singewald, N., Herzog, H., & Sperk, G. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.11.048 · Cited by 71 · cited 2×
“Y4 receptor deficient mice were shown to have reduced anxiety and depression like behavior (Painsipp et al., 2008), and Y2/Y4 double knockout mice showed further decreased depression levels (Tasan et al., 2009).”
Plasma neuropeptide Y in patients with major depressive disorder
Hashimoto, H., Onishi, H., Koide, S., Toshihiro, K., & Yamagami, S. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)13008-1 · Cited by 71
Kőrösi, A., Schotanus, S. M., Olivier, B., Roubos, E. W., & Kozicz, T. (2005) · Brain Research · doi:10.1016/j.brainres.2005.04.012 · Cited by 71
Michelson, D., Hargreaves, R. J., Alexander, R., Ceesay, P., Hietala, J. A., Lines, C., & Reines, S. A. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000065 · Cited by 71
Cited by
The Effects of Psychological Stress on Depression
Yang, L., Zhao, Y., Wang, Y., Liu, L., Zhang, X., Li, B., & Cui, R. (2015) · Current Neuropharmacology · doi:10.2174/1570159x1304150831150507 · Cited by 589
Postpartum depression: Etiology, treatment and consequences for maternal care
Brummelte, S., & Galea, L. A. M. (2016) · Hormones and Behavior · doi:10.1016/j.yhbeh.2015.08.008 · Cited by 567
Sex differences in depression: Insights from clinical and preclinical studies
Eid, R. S., Gobinath, A. R., & Galea, L. A. M. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.01.006 · Cited by 457
The Neuropeptide Tac2 Controls a Distributed Brain State Induced by Chronic Social Isolation Stress
Zelikowsky, M., Hui, M., Karigo, T., Choe, A., Yang, B., Blanco, M. R., Beadle, K., Gradinaru, V., Deverman, B. E., & Anderson, D. J. (2018) · Cell · doi:10.1016/j.cell.2018.03.037 · Cited by 286
Substance P and pain chronicity
Zieglgänsberger, W. (2019) · Cell and Tissue Research · doi:10.1007/s00441-018-2922-y · Cited by 276
Metadata
- Authors
- Kormos, V., & Gaszner, B.
- Venue
- Neuropeptides
- Publisher
- Elsevier BV
- Published
- 2013-12
- Volume
- 47
- Issue
- 6
- Pages
- 401-419
- ISSN
- 0143-4179 (ISSN-L)
- OpenAlex
- W1987212298
- Cited by
- 329
- References
- 270
- FWCI
- 12.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.